Trump unveils new drug price deal with Regeneron amid affordability push
The Washington Post • • business
Key Points:
- The drug company became the 17th to agree to reduce prices under the administration’s Most Favored Nation initiative.
- It will provide a new gene therapy free of charge as part of this agreement.
- President Donald Trump hosted drug company leaders in the Oval Office to highlight the voluntary price cuts.
- The administration aims to demonstrate to voters that Republicans are actively working to lower health care costs ahead of the midterm elections.
